Next Generation Sequencing (Ngs) Market - Global Professional Analysis and Forecast to 2026

Oct 14, 2019  |  152 PAGES  |  REPORT CODE: CMM209460
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Next Generation Sequencing (Ngs) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.7% during the forecast period.

This report presents the market size and development trends by detailing the Next Generation Sequencing (Ngs) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Next Generation Sequencing (Ngs) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Next Generation Sequencing (Ngs) industry and will help you to build a panoramic view of the industrial development.

Next Generation Sequencing (Ngs) Market, By Type:

  • 454-Sequencing

  • Illumina Sequencing

Next Generation Sequencing (Ngs) Market, By Application:

  • Oncology

  • Hereditary Disease Detection

  • Life Science

  • Emerging Application

Some of the leading players are as follows:

  • Qiagen N.V.

  • DNASTAR, Inc.

  • Illumina, Inc.

  • Multiplicom NV

  • Mayo Medical Laboratories and Mayo Clinic

  • DNA Electronics Ltd.

  • Roche

  • Quest Diagnostics

  • InDecations Exchange Pte Ltd (INEX)

  • QuantuMDx Group

  • Sequenta, Inc.

  • SeqLL, LLC

  • Response Genetics, Inc.

  • RainDance Technologies, Inc.

  • MolecularMD Corporation

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Next Generation Sequencing (Ngs) Market: Technology Type Analysis

  • 4.1 Next Generation Sequencing (Ngs) Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Next Generation Sequencing (Ngs) Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 454-Sequencing

    • 4.3.2 Illumina Sequencing

5 Next Generation Sequencing (Ngs) Market: Product Analysis

  • 5.1 Next Generation Sequencing (Ngs) Product Market Share Analysis, 2018 & 2026

  • 5.2 Next Generation Sequencing (Ngs) Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Next Generation Sequencing (Ngs) Market: Application Analysis

  • 6.1 Next Generation Sequencing (Ngs) Application Market Share Analysis, 2018 & 2026

  • 6.2 Next Generation Sequencing (Ngs) Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Oncology

    • 6.3.2 Hereditary Disease Detection

    • 6.3.3 Life Science

    • 6.3.4 Emerging Application

7 Next Generation Sequencing (Ngs) Market: Regional Analysis

  • 7.1 Next Generation Sequencing (Ngs) Regional Market Share Analysis, 2018 & 2026

  • 7.2 Next Generation Sequencing (Ngs) Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Qiagen N.V.

    • 9.1.1 Qiagen N.V. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 DNASTAR, Inc.

    • 9.2.1 DNASTAR, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Illumina, Inc.

    • 9.3.1 Illumina, Inc. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Multiplicom NV

    • 9.4.1 Multiplicom NV Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Mayo Medical Laboratories and Mayo Clinic

    • 9.5.1 Mayo Medical Laboratories and Mayo Clinic Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 DNA Electronics Ltd.

    • 9.6.1 DNA Electronics Ltd. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Roche

    • 9.7.1 Roche Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Quest Diagnostics

    • 9.8.1 Quest Diagnostics Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 InDecations Exchange Pte Ltd (INEX)

    • 9.9.1 InDecations Exchange Pte Ltd (INEX) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 QuantuMDx Group

    • 9.10.1 QuantuMDx Group Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sequenta, Inc.

    • 9.11.1 Sequenta, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 SeqLL, LLC

    • 9.12.1 SeqLL, LLC Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Response Genetics, Inc.

    • 9.13.1 Response Genetics, Inc. Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 RainDance Technologies, Inc.

    • 9.14.1 RainDance Technologies, Inc. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 MolecularMD Corporation

    • 9.15.1 MolecularMD Corporation Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 79 Figures and 162 Tables)

  • Figure 454-Sequencing Next Generation Sequencing (Ngs) market, 2015 - 2026 (USD Million)

  • Figure Illumina Sequencing Next Generation Sequencing (Ngs) market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Hereditary Disease Detection market, 2015 - 2026 (USD Million)

  • Figure Life Science market, 2015 - 2026 (USD Million)

  • Figure Emerging Application market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Next Generation Sequencing (Ngs) market, by country, 2015 - 2026 (USD Million)

  • Table North America Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table North America Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table North America Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Canada Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Canada Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Europe Next Generation Sequencing (Ngs) market, by country, 2015 - 2026 (USD Million)

  • Table Europe Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Europe Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Europe Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Germany Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Germany Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table France Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table France Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Italy Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Italy Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Spain Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Spain Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Next Generation Sequencing (Ngs) market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table China Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table China Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Japan Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Japan Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table India Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table India Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Next Generation Sequencing (Ngs) market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table MEA Next Generation Sequencing (Ngs) market, by country, 2015 - 2026 (USD Million)

  • Table MEA Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table MEA Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table MEA Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Next Generation Sequencing (Ngs) market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Next Generation Sequencing (Ngs) market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Next Generation Sequencing (Ngs) market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Qiagen N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DNASTAR, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Multiplicom NV Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mayo Medical Laboratories and Mayo Clinic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DNA Electronics Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Quest Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table InDecations Exchange Pte Ltd (INEX) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table QuantuMDx Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sequenta, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SeqLL, LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Response Genetics, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table RainDance Technologies, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MolecularMD Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top